Investment Themes  ›  Hospitals and Diagnostics Theme  ·  Active Funds Only

Hospitals and Diagnostics — Mutual Fund Holdings Tracker

Track how many active mutual funds hold hospital and diagnostics stocks in India. Monthly data shows where institutional conviction across Apollo Hospitals, Max Healthcare, Fortis, Narayana, Global Health, Metropolis, Dr Lal PathLabs and Thyrocare is rising or falling.

📅 Updated Jun 2026  ·  Index funds and ETFs excluded

8
Stocks Tracked
341
Active Funds Holding (Jun 2026)
₹62,604 Cr
Active MF Investment (Jun 2026)
Mar 2026 — fund count in Mar 2026 (base month) · Apr % / May % / Jun % — month-on-month change in funds holding the stock · Jun 2026 Funds — funds holding as of Jun 2026 · Overall % — total change Mar 2026 to Jun 2026. Blue = growing interest, Red = exiting · AUM (₹ Cr) — total market value held by active funds in Jun 2026 Active equity funds only  ·  Index funds and ETFs excluded
# Stock Name Mar Apr % May % Jun % Jun 2026 Funds Overall % AUM (₹ Cr)
1 Apollo Hospitals Enterprise LimitedHealthcare Services 143 +2.1%+4.1% -3.3% 147 +2.8% 13,422
2 Max Healthcare Institute LimitedHealthcare Services 113 +4.4%+3.4% +3.3% 126 +11.5% 14,831
3 Fortis Healthcare LimitedHealthcare Services 112 +1.8%+8.8% 0% 124 +10.7% 17,242
4 Dr. Lal Path Labs LimitedHealthcare Services 58 +12.1%+9.2% -5.6% 67 +15.5% 4,518
5 Global Health LimitedHealthcare Services 38 +18.4%+8.9% +10.2% 54 +42.1% 5,080
6 Metropolis Healthcare LimitedHealthcare Services 40 +2.5%+2.4% 0% 42 +5% 3,340
7 Narayana Hrudayalaya LimitedHealthcare Services 23 -4.3%+13.6% -4% 24 +4.3% 2,766
8 Thyrocare Technologies LimitedHealthcare Services 11 +36.4%+6.7% -6.3% 15 +36.4% 1,405
Share:

What are hospital and diagnostics stocks tracked by mutual funds in India?

Hospital and diagnostics stocks include operators of multi-specialty hospitals, day care centres, and pathology laboratory chains. The segment spans large hospital chains like Apollo Hospitals, Max Healthcare, Fortis Healthcare, Narayana Hrudayalaya, and Global Health (Medanta), alongside diagnostics players like Metropolis Healthcare, Dr Lal PathLabs and Thyrocare. India healthcare sector is undergoing rapid formalisation driven by rising health awareness, medical tourism, insurance penetration, and chronic disease management needs.

Rising fund counts over four months signal growing institutional conviction. Cross-reference individual fund portfolios on our top stocks page or explore full holdings via the funds directory.

Why are mutual funds buying hospital and diagnostics stocks in India right now?

India healthcare infrastructure is significantly underpenetrated relative to its population. Hospital bed density and doctor-to-patient ratios remain well below global averages, creating decades of capacity expansion opportunity. The growth of health insurance — both government schemes like Ayushman Bharat and private insurance — is driving formalisation of healthcare spending. Large hospital chains are expanding aggressively into tier 2 cities. Diagnostics players benefit from rising preventive health checkups.

For context on SEBI disclosure requirements, refer to AMFI India. For regulatory guidelines, visit SEBI India. Explore broader holding trends using our market cap categories page.

Are index funds and ETFs included in the hospital stock fund counts?

No — all counts exclude index funds, ETFs, and fund of funds. Only actively managed equity mutual funds are counted. Index funds mechanically hold stocks in proportion to index weight — their holdings do not reflect active manager conviction. By excluding them, fund counts here more accurately represent where professional stock pickers are actively building or reducing positions in India healthcare sector.

To explore individual fund portfolios, visit the funds directory or use the SIP calculator to plan investments in funds with high healthcare sector exposure. For a broader market view, see our AAUM data page.

Disclaimer: RightAdvise is a data and research platform. Fund holding data is sourced from monthly portfolio disclosures published by mutual funds as required by SEBI. This page is for informational purposes only and does not constitute investment advice. Past holding trends do not guarantee future performance. Please consult a SEBI-registered investment adviser before making any investment decisions.